Mira Pharmaceuticals (MIRA) has been identified as an extreme short squeeze candidate. With a short ratio of 56.6%, the stock is seeing significant bearish bets building up. This high level of shorting pressure, combined with its current price of $0.85, suggests that the stock is highly susceptible to volatility and potential short-covering rallies.
Signal data sourced from AltIndex. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.